arrow
M

Marianne Holm

chulalongkorn university
H指数:29
被引数:2.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Insights from the WHO Tricycle-aligned Fleming Fund EQASIA External Quality Assessment (EQA) programme detecting ESBL-, AmpC- and carbapenemase-producing Escherichia coli in South and South-East Asia

世卫组织三轮车式弗莱明基金EQASIA外部质量评估(EQA)计划对南亚和东南亚产超广谱β-内酰胺酶、AmpC酶和碳青霉烯酶的大肠杆菌的检测见解

2026-05-010
PRE
Prevalence, trend and resistance patterns of carbapenem-resistant Enterobacterales in Bangladesh: a nationwide laboratory-based study

孟加拉国碳青霉烯耐药肠杆菌科细菌的流行率、趋势及耐药模式:一项全国性实验室为基础的研究

2026-02-240
OAAI
Strengthening antimicrobial resistance diagnostics in National Reference Laboratories across One Health in South and Southeast Asia: impact of external quality assessment and targeted follow-up

加强南亚和东南亚“同一健康”框架下的国家参考实验室抗菌药物耐药性诊断能力:外部质量评估和针对性跟进的影响

2025-07-010
PRE
External quality assurance (EQA) network in South and South-East Asia: experience and results from an international EQA programme in One Health sector reference laboratories

南亚和东南亚的外部质量保证 (EQA) 网络: 一个卫生部门参考实验室的国际EQA计划的经验和结果

2025-02-040
OA
Evaluating Quality Management and Diagnostics Microbiology Performance Within an International External Quality Assessment (EQA) Program Serving National One Health Sector Reference Laboratories Across Asia: Experience Amid the Coronavirus Disease 2019 (COVID-19) Pandemic

在国际外部质量评估 (EQA) 计划中评估质量管理和诊断微生物学性能,为亚洲国家卫生部门参考实验室提供服务: 冠状病毒疾病2019 (新型冠状病毒肺炎) 大流行中的经验

2023-12-202
OAAI
Methodological Approach to Identify and Expand the Volume of Antimicrobial Resistance (AMR) Data in the Human Health Sector in Low- and Middle-Income Countries in Asia: Implications for Local and Regional AMR Surveillance Systems Strengthening

确定和扩大亚洲中低收入国家人类卫生部门抗微生物药物耐药性 (AMR) 数据量的方法: 加强地方和区域抗微生物药物耐药性监测系统的意义

2023-12-201
OAAI
Capturing Data on Antimicrobial Resistance Patterns and Trends in Use in Regions of Asia (CAPTURA)

获取亚洲地区抗菌素耐药性模式和使用趋势的数据 (CAPTURA)

2023-12-203
OAAI
Effective Stakeholder Engagement for Collation, Analysis and Expansion of Antimicrobial Resistance (AMR) Data: A CAPTURA Experience

有效的利益相关者参与抗菌素耐药性 (AMR) 数据的整理,分析和扩展: CAPTURA经验

2023-12-204
OAAI
CAPTURA Regional Workshop Proceedings (28-30 June 2022, Virtual)

CAPTURA区域研讨会论文集 (2022年6月30日28日,虚拟)

2023-12-201
OAAI
Utility and Evaluation of Applied Project Management Processes Within a Large Multicountry Health Systems Development Project Conducted During the Coronavirus Disease 2019 (COVID-19) Pandemic

在冠状病毒疾病2019 (新型冠状病毒肺炎) 大流行期间进行的大型多国卫生系统开发项目中应用项目管理流程的效用和评估

2023-12-201
OAAI
The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019

可归因于风险因素的全球癌症负担,2010-19: 对全球疾病负担研究2019的系统分析

LANCET
IF88.5
2022-08-01418
OAAI
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis

细菌耐药性2019年的全球负担: 系统分析

LANCET
IF88.5
2022-02-016.7K
OAAI